12/19
10:02 am
crl
Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects [Yahoo! Finance]
Low
Report
Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects [Yahoo! Finance]
12/19
08:07 am
crl
Animal Model Market Size Projected to Reach USD 4.6 Billion by 2032 – Research by SNS Insider [Yahoo! Finance]
Low
Report
Animal Model Market Size Projected to Reach USD 4.6 Billion by 2032 – Research by SNS Insider [Yahoo! Finance]
12/13
11:16 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Bank of America Co. from $220.00 to $210.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Bank of America Co. from $220.00 to $210.00. They now have a "neutral" rating on the stock.
12/11
07:40 am
crl
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033 [Yahoo! Finance]
Low
Report
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033 [Yahoo! Finance]
12/10
11:08 am
crl
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 [Yahoo! Finance]
Low
Report
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 [Yahoo! Finance]
12/6
01:00 pm
crl
Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? [Yahoo! Finance]
12/5
05:41 pm
crl
Clinical Trials Market in the US to grow by USD 5 Billion from 2024-2028, driven by more drug trials, with AI redefining market trends - Technavio [Yahoo! Finance]
Low
Report
Clinical Trials Market in the US to grow by USD 5 Billion from 2024-2028, driven by more drug trials, with AI redefining market trends - Technavio [Yahoo! Finance]
12/5
08:10 am
crl
Charles River Introduces Global Biotech Incubator Program [Yahoo! Finance]
Medium
Report
Charles River Introduces Global Biotech Incubator Program [Yahoo! Finance]
12/5
08:00 am
crl
Charles River Introduces Global Biotech Incubator Program
Medium
Report
Charles River Introduces Global Biotech Incubator Program
12/2
09:20 am
crl
Pharmaceutical Analytical Testing Outsourcing Business Analysis Report 2024: Market to Reach $16.3 Billion by 2030 - Stringent Regulatory Requirements from Global Health Authorities Fuels Growth [Yahoo! Finance]
Low
Report
Pharmaceutical Analytical Testing Outsourcing Business Analysis Report 2024: Market to Reach $16.3 Billion by 2030 - Stringent Regulatory Requirements from Global Health Authorities Fuels Growth [Yahoo! Finance]
12/2
08:00 am
crl
Charles River Laboratories to Present at Evercore ISI Investor Conference
Low
Report
Charles River Laboratories to Present at Evercore ISI Investor Conference
11/28
01:31 pm
crl
At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List? [Yahoo! Finance]
Low
Report
At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List? [Yahoo! Finance]
11/28
08:34 am
crl
Is it the Right Time to Hold Charles River Stock in Your Portfolio? [Yahoo! Finance]
Low
Report
Is it the Right Time to Hold Charles River Stock in Your Portfolio? [Yahoo! Finance]
11/26
10:57 am
crl
How CROs Are Transforming Global Research and Development [Yahoo! Finance]
Low
Report
How CROs Are Transforming Global Research and Development [Yahoo! Finance]
11/21
11:02 am
crl
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
Low
Report
Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]
11/18
10:29 am
crl
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
Low
Report
EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]
11/18
08:50 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
11/14
09:34 am
crl
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
Medium
Report
Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]
11/13
01:14 pm
crl
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
Low
Report
Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]
11/13
12:31 pm
crl
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
Low
Report
'Serious risks': Researchers join push against importing monkeys for drug testing [Yahoo! Finance Canada]
11/12
07:30 am
crl
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
Low
Report
Bioanalytical Testing Services Market to Surpass USD 9.22 Billion by 2032, Predicted CAGR of 9.4%| Polaris Market Research [Yahoo! Finance]
11/11
11:18 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at TD Cowen from $203.00 to $227.00. They now have a "hold" rating on the stock.
11/11
08:00 am
crl
Charles River Laboratories to Present at UBS and Jefferies Conferences
Low
Report
Charles River Laboratories to Present at UBS and Jefferies Conferences
11/8
06:36 am
crl
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/7
11:20 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $240.00 to $250.00. They now have a "buy" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $240.00 to $250.00. They now have a "buy" rating on the stock.